Bárbara Manuella Cardoso Sodré Alves
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Bárbara Manuella Cardoso Sodré Alves has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- Rodrigo Fonseca Lima
Universidade de Brasília
5 shared publications - Rafael Santos Santana
Universidade de Brasília
4 shared publications - Tiago Marques dos Reis
Universidade Federal de Alfenas
3 shared publications - Wildo Navegantes de Araújo
Universidade de Brasília, Brasil
3 shared publications - Adriana Ilha da Silva
Universidade Federal do Espírito Santo, Brasil
2 shared publications - Alberto Novaes Ramos Junior
Universidade Federal do Ceará, Brazil
2 shared publications
Latest Publications
- Open Access
- 22 March 2025
- Published by Sociedade Brasileira de Medicina de Familia e Comunidade (SBMFC) in Revista Brasileira de Medicina de Família e Comunidade
- Vol. 20 (47) , 3991
Management of acute cough
Introduction: Cough is one of the main causes of demand for care in primary care, as it affects the patient’s quality of life. An acute cough is considered a self-limiting problem because it is of low severity and has a short latency period. Objective: The aim of this study was to evaluate the quality of clinical guidelines (CGs) for the treatment of acute cough. Methods: Searches were carried out on the websites of national and international institutions and organizations using the descriptors “cough,” “tos,” “practice guideline,” “guideline,” and “guide of clinical practice.” The selected guidelines were evaluated by four reviewers using the Appraisal of Guidelines for Research & Evaluation (AGREE II) instrument, and then, they were classified as strongly recommended, recommended with modifications, and non-recommended. Results: A total of 11 international guidelines were selected, published between 2006 and 2019, most from the United States of America. A total of seven guidelines were specific to the treatment of acute cough, only one guideline was focused on pharmaceutical care, and six were focused on the treatment of adults and children. Scope and purpose were the domains that presented the best score; editorial independence (D6) had the highest score variation (0–98%); and applicability (D5) of guidelines had the lowest mean score, 46% (range 2–88%). Regarding interventions, most of the guidelines referred to pharmacological interventions as unnecessary and the most cited non-pharmacological intervention was menthol (ointment). Conclusions: Therefore, it is necessary to carry out more clinical studies of good quality so that the CGs can be revised, to make the recommendations more reliable.
- 22 March 2025
- Published by Sociedade Brasileira de Medicina de Familia e Comunidade (SBMFC) in Revista Brasileira de Medicina de Família e Comunidade
- Vol. 20 (47) , 3991
Open AccessManagement of acute cough
Introduction: Cough is one of the main causes of demand for care in primary care, as it affects the patient’s quality of life. An acute cough is considered a self-limiting problem because it is of low severity and has a short latency period. Objective: The aim of this study was to evaluate the quality of clinical guidelines (CGs) for the treatment of acute cough. Methods: Searches were carried out on the websites of national and international institutions and organizations using the descriptors “cough,” “tos,” “practice guideline,” “guideline,” and “guide of clinical practice.” The selected guidelines were evaluated by four reviewers using the Appraisal of Guidelines for Research & Evaluation (AGREE II) instrument, and then, they were classified as strongly recommended, recommended with modifications, and non-recommended. Results: A total of 11 international guidelines were selected, published between 2006 and 2019, most from the United States of America. A total of seven guidelines were specific to the treatment of acute cough, only one guideline was focused on pharmaceutical care, and six were focused on the treatment of adults and children. Scope and purpose were the domains that presented the best score; editorial independence (D6) had the highest score variation (0–98%); and applicability (D5) of guidelines had the lowest mean score, 46% (range 2–88%). Regarding interventions, most of the guidelines referred to pharmacological interventions as unnecessary and the most cited non-pharmacological intervention was menthol (ointment). Conclusions: Therefore, it is necessary to carry out more clinical studies of good quality so that the CGs can be revised, to make the recommendations more reliable.
- Open Access
- 5 July 2024
- Published by Jornal de Assistencia Farmaceutica e Farmacoeconomia in JORNAL DE ASSISTÊNCIA FARMACÊUTICA E FARMACOECONOMIA
- Vol. 9 (3)
Guideline for managing fever in the context of pharmaceutical care
Objective: To systematize, through evidence-based practice, the management of self-li-miting cases of fever in the context of Pharmaceutical Care. Methods: To prepare the guideline, the ADAPTE method was adopted as a structured process for reviewing the literature and cons-tructing the document. The AGREE II and GRADE tools were also used to analyze the practice guidelines selected during the process and to categorize the evidence, respectively. Results: After elaboration, it was observed that the pharmaceutical anamnesis is an important step in confirming whether the fever is just an episode or whether it is associated with a state of disorientation in the patient; persistent tachycardia; tachypnea, hypertension and/or postu-ral hypotension, as well as its duration for referral purposes. Among the non-pharmacological measures, fluid intake is the most recommended in order to avoid the risk of dehydration, as well as health education actions to avoid external methods of lowering the temperature, such as cold baths or baths with alcohol, as well as recommending cool environments, correct temperature measurement and the disposal of thermometers. Pharmacological treat-ment should be carefully evaluated, as it is only indicated for relieving signs of discomfort, giving preference to Ibuprofen and Paracetamol. Conclusion: Despite being a beneficial physio-logical process, caution is needed in vulnerable populations, such as the first three months of a child’s life, pregnant women, puerperal women and patients taking medications such as corticosteroids, immunosuppressants or polypharmacy and the elderly.
- 5 July 2024
- Published by Jornal de Assistencia Farmaceutica e Farmacoeconomia in JORNAL DE ASSISTÊNCIA FARMACÊUTICA E FARMACOECONOMIA
- Vol. 9 (3)
Open AccessGuideline for managing fever in the context of pharmaceutical care
Objective: To systematize, through evidence-based practice, the management of self-li-miting cases of fever in the context of Pharmaceutical Care. Methods: To prepare the guideline, the ADAPTE method was adopted as a structured process for reviewing the literature and cons-tructing the document. The AGREE II and GRADE tools were also used to analyze the practice guidelines selected during the process and to categorize the evidence, respectively. Results: After elaboration, it was observed that the pharmaceutical anamnesis is an important step in confirming whether the fever is just an episode or whether it is associated with a state of disorientation in the patient; persistent tachycardia; tachypnea, hypertension and/or postu-ral hypotension, as well as its duration for referral purposes. Among the non-pharmacological measures, fluid intake is the most recommended in order to avoid the risk of dehydration, as well as health education actions to avoid external methods of lowering the temperature, such as cold baths or baths with alcohol, as well as recommending cool environments, correct temperature measurement and the disposal of thermometers. Pharmacological treat-ment should be carefully evaluated, as it is only indicated for relieving signs of discomfort, giving preference to Ibuprofen and Paracetamol. Conclusion: Despite being a beneficial physio-logical process, caution is needed in vulnerable populations, such as the first three months of a child’s life, pregnant women, puerperal women and patients taking medications such as corticosteroids, immunosuppressants or polypharmacy and the elderly.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Epidemiologia e Serviços de Saúde
- Vol. 33 (spe2) , e20231308
Vaccine coverage by social strata in state capitals in the Brazilian Midwest region: a household survey of children born in 2017 and 2018
Objective To analyze full vaccination coverage in live births in 2017 and 2018 in the capitals of the Midwest region of Brazil, according to social strata. Methods Population-based household survey with cluster sampling. Full coverage in children at 12 and 24 months of age and sociodemographic factors were analyzed. Results 5,715 children were analyzed. Full coverage at 12 months of age was 67.9% (95%CI 65.4;70.4), while at 24 months it was 48.2% (95%CI 45.3;51.1). Pneumococcal vaccine had the highest vaccination coverage (91.3%), while the second dose of rotavirus vaccine had the lowest (74.2%). In Campo Grande, no vaccine reached coverage above 90%, with BCG (82.9%) and hepatitis B (82.1%) standing out. Campo Grande and Brasília had the worst vaccination coverage in the high social stratum (24 months of age). Conclusion Vaccination coverage in the Midwest was below 80%, falling short of the recommended target and associated with socioeconomic factors.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Epidemiologia e Serviços de Saúde
- Vol. 33 (spe2) , e20231308
Open AccessVaccine coverage by social strata in state capitals in the Brazilian Midwest region: a household survey of children born in 2017 and 2018
Objective To analyze full vaccination coverage in live births in 2017 and 2018 in the capitals of the Midwest region of Brazil, according to social strata. Methods Population-based household survey with cluster sampling. Full coverage in children at 12 and 24 months of age and sociodemographic factors were analyzed. Results 5,715 children were analyzed. Full coverage at 12 months of age was 67.9% (95%CI 65.4;70.4), while at 24 months it was 48.2% (95%CI 45.3;51.1). Pneumococcal vaccine had the highest vaccination coverage (91.3%), while the second dose of rotavirus vaccine had the lowest (74.2%). In Campo Grande, no vaccine reached coverage above 90%, with BCG (82.9%) and hepatitis B (82.1%) standing out. Campo Grande and Brasília had the worst vaccination coverage in the high social stratum (24 months of age). Conclusion Vaccination coverage in the Midwest was below 80%, falling short of the recommended target and associated with socioeconomic factors.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Epidemiologia e Serviços de Saúde
- Vol. 33 (spe2) , e20231308
Coberturas vacinais por estrato social nas capitais da região Centro-Oeste do Brasil: inquérito domiciliar em coorte de crianças nascidas em 2017 e 2018
RESUMO Objetivo Analisar a cobertura vacinal completa em nascidos vivos em 2017 e 2018, nas capitais da região Centro-Oeste do Brasil, segundo estratos sociais. Métodos Inquérito domiciliar de base populacional com amostragem por conglomerados. Analisou-se a cobertura vacinal completa em crianças aos 12 e 24 meses de idade e os fatores sociodemográficos. Resultados Foram analisadas 5.715 crianças. A cobertura completa aos 12 meses de idade foi 67,9% (IC95% 65,4;70,4) e aos 24 meses de idade foi 48,2% (IC95% 45,3;51,1). A maior cobertura foi da vacina pneumococo (91,3%) e a pior da segunda dose da vacina rotavírus (74,2%). Em Campo Grande, nenhuma vacina alcançou cobertura acima de 90%, destacando-se as vacinas BCG (82,9%) e hepatite B (82,1%). Campo Grande e Brasília tiveram piores coberturas vacinais no estrato social alto (24 meses de idade). Conclusão A cobertura vacinal na região Centro-Oeste foi inferior a 80%, abaixo da meta preconizada e associada com fatores socioeconômicos.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Epidemiologia e Serviços de Saúde
- Vol. 33 (spe2) , e20231308
Open AccessCoberturas vacinais por estrato social nas capitais da região Centro-Oeste do Brasil: inquérito domiciliar em coorte de crianças nascidas em 2017 e 2018
RESUMO Objetivo Analisar a cobertura vacinal completa em nascidos vivos em 2017 e 2018, nas capitais da região Centro-Oeste do Brasil, segundo estratos sociais. Métodos Inquérito domiciliar de base populacional com amostragem por conglomerados. Analisou-se a cobertura vacinal completa em crianças aos 12 e 24 meses de idade e os fatores sociodemográficos. Resultados Foram analisadas 5.715 crianças. A cobertura completa aos 12 meses de idade foi 67,9% (IC95% 65,4;70,4) e aos 24 meses de idade foi 48,2% (IC95% 45,3;51,1). A maior cobertura foi da vacina pneumococo (91,3%) e a pior da segunda dose da vacina rotavírus (74,2%). Em Campo Grande, nenhuma vacina alcançou cobertura acima de 90%, destacando-se as vacinas BCG (82,9%) e hepatite B (82,1%). Campo Grande e Brasília tiveram piores coberturas vacinais no estrato social alto (24 meses de idade). Conclusão A cobertura vacinal na região Centro-Oeste foi inferior a 80%, abaixo da meta preconizada e associada com fatores socioeconômicos.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Cadernos de Saude Publica
- Vol. 40 (5) , e00016423
Lists of potentially inappropriate medications for older people in primary care: a systematic review of health outcomes
This study is a systematic literature review of the association between lists of potentially inappropriate medications (PIM) in clinical practice and health outcomes of older adults followed up in primary health care. For this purpose, the PRISMA protocol was used to systematize the search for articles in the PubMed, Web of Science, Scopus, Cochrane Central, LIVIVO and LILACS databases, in addition to the gray literature. Studies with randomized clinical trials were selected, using explicit criteria (lists) for the identification and management of PIM in prescriptions of older patients in primary care. Of the 2,400 articles found, six were used for data extraction. The interventions resulted in significant reductions in the number of PIM and adverse drug events and, consequently, in potentially inappropriate prescriptions (PIP) in polymedicated older adults. However, there were no significant effects of the interventions on negative clinical outcomes, such as emergency room visits, hospitalizations and death, or on improving the health status of the older adults. The use of PIM lists promotes adequate medication prescriptions for older adults in primary health care, but further studies are needed to determine the impact of reducing PIM on primary clinical outcomes.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Cadernos de Saude Publica
- Vol. 40 (5) , e00016423
Open AccessLists of potentially inappropriate medications for older people in primary care: a systematic review of health outcomes
This study is a systematic literature review of the association between lists of potentially inappropriate medications (PIM) in clinical practice and health outcomes of older adults followed up in primary health care. For this purpose, the PRISMA protocol was used to systematize the search for articles in the PubMed, Web of Science, Scopus, Cochrane Central, LIVIVO and LILACS databases, in addition to the gray literature. Studies with randomized clinical trials were selected, using explicit criteria (lists) for the identification and management of PIM in prescriptions of older patients in primary care. Of the 2,400 articles found, six were used for data extraction. The interventions resulted in significant reductions in the number of PIM and adverse drug events and, consequently, in potentially inappropriate prescriptions (PIP) in polymedicated older adults. However, there were no significant effects of the interventions on negative clinical outcomes, such as emergency room visits, hospitalizations and death, or on improving the health status of the older adults. The use of PIM lists promotes adequate medication prescriptions for older adults in primary health care, but further studies are needed to determine the impact of reducing PIM on primary clinical outcomes.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 57, e004022024
Isoniazid use, effectiveness, and safety for treatment of latent tuberculosis infection: a systematic review
The treatment strategy for latent tuberculosis infection is to reduce the number of tuberculosis cases and consequently reduce the transmission of pathogenic bacteria. This study aimed to determine the safety, effectiveness, and adherence of isoniazid use for latent tuberculosis infection treatment.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 57, e004022024
Open AccessIsoniazid use, effectiveness, and safety for treatment of latent tuberculosis infection: a systematic review
The treatment strategy for latent tuberculosis infection is to reduce the number of tuberculosis cases and consequently reduce the transmission of pathogenic bacteria. This study aimed to determine the safety, effectiveness, and adherence of isoniazid use for latent tuberculosis infection treatment.
- Open Access
- 5 June 2023
- Published by Wiley
Use, effectiveness and safety of isoniazid in the treatment of latent tuberculosis infection, what do we know?
Background The treatment strategy for latent tuberculosis (TB) infection (LTBI) aims to promote a reduction in the number of cases that develop into TB and, consequently, a reduction in the transmission of pathogenic bacteria. Objectives The objective was to know the safety, effectiveness and adherence of the use of INH in two pharmaceutical presentations (300mg or 100mg tablet) reported in scientific studies. Methods A review protocol was registered a priori with PROSPERO (number CRD42020176694). The electronic databases Cochrane; PubMed; Embase; LILACS, Scopus, and Web of Science were searched for studies on use of INH for LTBI. The results and methods were presented in line with the PRISMA guidelines, and the methodological quality of the included reviews was assessed using the Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies. Results Most of the studies used isoniazid (H) as a treatment for LTBI, with a duration of 9 months. There was significant variation in the of use of isoniazid, ranging from 0.3% to 98.6% of the participants. A similar variation was found in the 52 studies that similarly presented the rate of adherence to treatment with H, which ranged from 18% to 100% among study participants completing INH treatment for LTBI. In studies, the adverse events reported most frequent events reported were included hepatotoxicity, gastric intolerance, and neuropathy, the rates of occurrence of these with isoniazid, rang from < 1% to 48%. In the studies that evaluated effectiveness of isoniazid for latent tuberculosis infection, a variation from 0 to 19.7% of people who did not have active TB after the follow-up period was observed, with the highest rate among HIV-positive individuals. Conclusion Our findings indicate that isoniazid is being widely used in the world as a prophylactic treatment for tuberculosis, rates of adherence to isoniazid were above 50%. It is important to emphasize the importance of keeping the follow-up of the person who uses isoniazid due to the risk of developing unwanted events resulting from the drug. Even with treatment challenges, we identified low rates of people who used isoniazid and developed active tuberculosis during the period they were followed. We believe that isoniazid continues to contribute to tuberculosis control in the world and better care actions are needed.
- 5 June 2023
- Published by Wiley
Open AccessUse, effectiveness and safety of isoniazid in the treatment of latent tuberculosis infection, what do we know?
Background The treatment strategy for latent tuberculosis (TB) infection (LTBI) aims to promote a reduction in the number of cases that develop into TB and, consequently, a reduction in the transmission of pathogenic bacteria. Objectives The objective was to know the safety, effectiveness and adherence of the use of INH in two pharmaceutical presentations (300mg or 100mg tablet) reported in scientific studies. Methods A review protocol was registered a priori with PROSPERO (number CRD42020176694). The electronic databases Cochrane; PubMed; Embase; LILACS, Scopus, and Web of Science were searched for studies on use of INH for LTBI. The results and methods were presented in line with the PRISMA guidelines, and the methodological quality of the included reviews was assessed using the Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies. Results Most of the studies used isoniazid (H) as a treatment for LTBI, with a duration of 9 months. There was significant variation in the of use of isoniazid, ranging from 0.3% to 98.6% of the participants. A similar variation was found in the 52 studies that similarly presented the rate of adherence to treatment with H, which ranged from 18% to 100% among study participants completing INH treatment for LTBI. In studies, the adverse events reported most frequent events reported were included hepatotoxicity, gastric intolerance, and neuropathy, the rates of occurrence of these with isoniazid, rang from < 1% to 48%. In the studies that evaluated effectiveness of isoniazid for latent tuberculosis infection, a variation from 0 to 19.7% of people who did not have active TB after the follow-up period was observed, with the highest rate among HIV-positive individuals. Conclusion Our findings indicate that isoniazid is being widely used in the world as a prophylactic treatment for tuberculosis, rates of adherence to isoniazid were above 50%. It is important to emphasize the importance of keeping the follow-up of the person who uses isoniazid due to the risk of developing unwanted events resulting from the drug. Even with treatment challenges, we identified low rates of people who used isoniazid and developed active tuberculosis during the period they were followed. We believe that isoniazid continues to contribute to tuberculosis control in the world and better care actions are needed.
- Open Access
- 6 February 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (3)
Quality appraisal of clinical guidelines for the management of constipation according to AGREE II instrument
Constipation is one of the most frequent complaints in health establishments, affecting approximately 20% of the world population. The key to the successful management of this disorder is its early identification and immediate treatment with nondrug measures as the main therapeutic alternative. While clinical guidelines are informative documents that include recommendations aimed at optimizing patient care, this study aims to evaluate the quality of these documents available in the management of this condition. This study evaluated clinical guidelines available in databases, scientific societies and class councils, which had as their theme the management of constipation. The methodology used to evaluate the quality of these documents was the application of the AGREE II instrument. Kappa test of agreement between evaluators was applied to corroborate uniformity in application of the AGREE II instrument. Of the eleven documents analyzed, only three presented the criteria for recommendation proposed for use in clinical practice, with a general average of quality indexes ranging from 93 to 72%. One guideline was recommended with modifications in its structure, with a general average of quality indexes of 44%. The mean overall score among the analyzed documents was 49.01%. Methodological care and expression of information in a concise and clear way, both of the content and methodology employed, result in documents of great quality, however, no aspects were present in most of the guidelines analyzed. Furthermore, it is observed that there are still points that should be improved.
- 6 February 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (3)
Open AccessQuality appraisal of clinical guidelines for the management of constipation according to AGREE II instrument
Constipation is one of the most frequent complaints in health establishments, affecting approximately 20% of the world population. The key to the successful management of this disorder is its early identification and immediate treatment with nondrug measures as the main therapeutic alternative. While clinical guidelines are informative documents that include recommendations aimed at optimizing patient care, this study aims to evaluate the quality of these documents available in the management of this condition. This study evaluated clinical guidelines available in databases, scientific societies and class councils, which had as their theme the management of constipation. The methodology used to evaluate the quality of these documents was the application of the AGREE II instrument. Kappa test of agreement between evaluators was applied to corroborate uniformity in application of the AGREE II instrument. Of the eleven documents analyzed, only three presented the criteria for recommendation proposed for use in clinical practice, with a general average of quality indexes ranging from 93 to 72%. One guideline was recommended with modifications in its structure, with a general average of quality indexes of 44%. The mean overall score among the analyzed documents was 49.01%. Methodological care and expression of information in a concise and clear way, both of the content and methodology employed, result in documents of great quality, however, no aspects were present in most of the guidelines analyzed. Furthermore, it is observed that there are still points that should be improved.
- Open Access
- 1 November 2021
- Published by FapUNIFESP (SciELO) in Ciencia & Saude Coletiva
- Vol. 26 (11) , 5577-5588
The quality of research on judicialization and its influence on public policies on access to medicines in Brazil: a systematic review
Patients without access to medicines often resort to the judicial system. However, no systematic review has discussed the quality of studies and the factors that may influence the access to medicines from judicialization. This study aimed to characterize the quality of research on access to judicialized medicines and their influence on public policies in Brazil. A search was conducted in the LILACS, PubMed/Medline, Scopus, and Web of Science databases using the terms “judicialization” and “medication”. Two reviewers identified articles that met the inclusion criteria. Only studies written in English, Portuguese, or Spanish published from 1990 to 2018 were included. The study selection resulted in a final sample of 45 articles. The retrospective descriptive design was the most common methods, based on reports and lawsuits. A high level of heterogeneity among the studies hindered the comparison and generation of evidence capable of supporting judges’ decisions based on technical-scientific criteria. This review showed that studies were heterogeneous and had low methodological quality. Moreover, they did not propose viable solutions for health managers and formulators to face the problem.
- 1 November 2021
- Published by FapUNIFESP (SciELO) in Ciencia & Saude Coletiva
- Vol. 26 (11) , 5577-5588
Open AccessThe quality of research on judicialization and its influence on public policies on access to medicines in Brazil: a systematic review
Patients without access to medicines often resort to the judicial system. However, no systematic review has discussed the quality of studies and the factors that may influence the access to medicines from judicialization. This study aimed to characterize the quality of research on access to judicialized medicines and their influence on public policies in Brazil. A search was conducted in the LILACS, PubMed/Medline, Scopus, and Web of Science databases using the terms “judicialization” and “medication”. Two reviewers identified articles that met the inclusion criteria. Only studies written in English, Portuguese, or Spanish published from 1990 to 2018 were included. The study selection resulted in a final sample of 45 articles. The retrospective descriptive design was the most common methods, based on reports and lawsuits. A high level of heterogeneity among the studies hindered the comparison and generation of evidence capable of supporting judges’ decisions based on technical-scientific criteria. This review showed that studies were heterogeneous and had low methodological quality. Moreover, they did not propose viable solutions for health managers and formulators to face the problem.
- Open Access
- 15 April 2021
- Published by Revista Brasileira de Farmacia Hospitalar e Servicos de Saude in Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde
- Vol. 12 (2) , 609
O que mudou nos serviços farmacêuticos hospitalares em uma região de saúde do Distrito Federal (Brasil) após três anos do diagnóstico inicial?
Objetivo: Reavaliar os serviços de Farmácia Hospitalar (FH) de dois hospitais públicos do Distrito Federal (DF-Brasil) em uma perspectiva de comparação temporal após três anos do diagnóstico situacional inicial. MétodoS: Estudo transversal envolvendo dois hospitais gerais de grande porte coordenados pela mesma superintendência da Secretaria de Saúde do DF (SES-DF) e cujos serviços farmacêuticos foram avaliados no final do ano de 2016. A segunda avaliação foi realizada em janeiro de 2020 e as FH foram caracterizadas conforme sua área, funcionamento e recursos humanos e avaliadas considerando indicadores de estrutura e processo referentes a serviços farmacêuticos gerenciais e assistenciais. Depois, as FH foram reavaliadas por meio da aplicação do algoritmo de pontuação a partir da identificação de características obrigatórias, não obrigatórias e indesejáveis e calculados percentuais de aproximação de cumprimento dos serviços em comparação ao ideal. As FH foram ainda avaliadas quanto ao seu apoio na gestão de riscos. Resultados: O algoritmo possibilitou verificar que as duas FH apresentaram melhora na porcentagem de cumprimento dos serviços em relação ao ideal. Na FH1, o aumento na porcentagem se deu como resposta a uma maior apresentação de itens obrigatórios dos componentes de seleção, informação e ensino e pesquisa. Na FH2 pesaram positivamente os serviços de distribuição e gerenciamento. Também houve evolução importante na perspectiva de atividades de apoio à gestão de riscos e segurança do paciente. Essa melhora geral se deu sem uma melhora estrutural e de quantidade de recursos humanos em termos de proporção de farmacêutico por leito. Conclusões: Os resultados sugerem melhora dos serviços a pesar de manutenção da inadequação de área e de quantidade de profissional farmacêutico e remontam a importância de adequação das práticas e constante monitoramento dos serviços com vistas a tornar os serviços mais qualificados e seguros e que tenham impacto positivo em termos de agregar valor aos processos dadas as demandas de atores internos e externos.
- 15 April 2021
- Published by Revista Brasileira de Farmacia Hospitalar e Servicos de Saude in Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde
- Vol. 12 (2) , 609
Open AccessO que mudou nos serviços farmacêuticos hospitalares em uma região de saúde do Distrito Federal (Brasil) após três anos do diagnóstico inicial?
Objetivo: Reavaliar os serviços de Farmácia Hospitalar (FH) de dois hospitais públicos do Distrito Federal (DF-Brasil) em uma perspectiva de comparação temporal após três anos do diagnóstico situacional inicial. MétodoS: Estudo transversal envolvendo dois hospitais gerais de grande porte coordenados pela mesma superintendência da Secretaria de Saúde do DF (SES-DF) e cujos serviços farmacêuticos foram avaliados no final do ano de 2016. A segunda avaliação foi realizada em janeiro de 2020 e as FH foram caracterizadas conforme sua área, funcionamento e recursos humanos e avaliadas considerando indicadores de estrutura e processo referentes a serviços farmacêuticos gerenciais e assistenciais. Depois, as FH foram reavaliadas por meio da aplicação do algoritmo de pontuação a partir da identificação de características obrigatórias, não obrigatórias e indesejáveis e calculados percentuais de aproximação de cumprimento dos serviços em comparação ao ideal. As FH foram ainda avaliadas quanto ao seu apoio na gestão de riscos. Resultados: O algoritmo possibilitou verificar que as duas FH apresentaram melhora na porcentagem de cumprimento dos serviços em relação ao ideal. Na FH1, o aumento na porcentagem se deu como resposta a uma maior apresentação de itens obrigatórios dos componentes de seleção, informação e ensino e pesquisa. Na FH2 pesaram positivamente os serviços de distribuição e gerenciamento. Também houve evolução importante na perspectiva de atividades de apoio à gestão de riscos e segurança do paciente. Essa melhora geral se deu sem uma melhora estrutural e de quantidade de recursos humanos em termos de proporção de farmacêutico por leito. Conclusões: Os resultados sugerem melhora dos serviços a pesar de manutenção da inadequação de área e de quantidade de profissional farmacêutico e remontam a importância de adequação das práticas e constante monitoramento dos serviços com vistas a tornar os serviços mais qualificados e seguros e que tenham impacto positivo em termos de agregar valor aos processos dadas as demandas de atores internos e externos.